RALDESY Trademark
Trademark Overview
On Wednesday, October 9, 2024, a trademark application was filed for RALDESY with the United States Patent and Trademark Office. The USPTO has given the RALDESY trademark a serial number of 98793378. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, July 30, 2025. This trademark is owned by Rubicon Research Private Limited. The RALDESY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals for the prevention and treatment of anxiety, depression, hypertension, cardiovascular disorders, sleep disorders, psychotic conditions, attention-deficit hyperactivity disorder, diabetes, Parkinson's disease; Medicinal preparations for prevention and treatment of anxiety, depression, hypertension, cardiovascular disorders, sleep disorders, psychotic conditions, attention-deficit hyperactivity disorder, diabetes, Parkinson's disease
General Information
| Serial Number | 98793378 |
| Word Mark | RALDESY |
| Filing Date | Wednesday, October 9, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Wednesday, July 30, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 19, 2025 |
Trademark Statements
| Description of Mark | The mark consists of the wording "RALDESY" in white inside a trapezium that fades in color from pink on the left, to purple in the middle, to blue on the right. |
| Goods and Services | Pharmaceuticals for the prevention and treatment of anxiety, depression, hypertension, cardiovascular disorders, sleep disorders, psychotic conditions, attention-deficit hyperactivity disorder, diabetes, Parkinson's disease; Medicinal preparations for prevention and treatment of anxiety, depression, hypertension, cardiovascular disorders, sleep disorders, psychotic conditions, attention-deficit hyperactivity disorder, diabetes, Parkinson's disease |
| Indication of Colors claimed | The colors pink, purple, blue, and white are claimed as a feature of the mark. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 10, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Rubicon Research Private Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 11 - Company |
| Address | Maharashtra 400604
IN |
Trademark Events
| Event Date | Event Description |
| Thursday, October 10, 2024 | NEW APPLICATION ENTERED |
| Monday, April 14, 2025 | ASSIGNED TO EXAMINER |
| Friday, April 11, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, April 11, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, April 14, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, April 14, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, April 14, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, July 14, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 14, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, July 14, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 15, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 13, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
